Malek B. Hannouf

Stereotactic Body Radiotherapy Versus Surgery for Medically Operable Stage I Non–Small-Cell Lung Cancer: A Markov Model–Based Decision Analysis

Alexander V. Louie, George Rodrigues, Malek B. Hannouf et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 66 citations

Non–small-cell Lung Cancer, Medically Operable Stage, Surgical Oncology +10

Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: Outcomes of a markov model analysis

Alexander V. Louie, George Rodrigues, Malek B. Hannouf et al. · Radiotherapy and Oncology · 2011 · 56 citations

Adaptive Radiotherapy, Radiation Therapy, Geriatrics +9

Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer

Malek B. Hannouf, Chander Sehgal, Jeffrey Cao et al. · PLoS ONE · 2012 · 39 citations · Full text

Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer

Malek B. Hannouf, Bin Xie, Muriel Brackstone et al. · BMC Cancer · 2012 · 33 citations · Full text

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer

Malek B. Hannouf, Gregory S. Zaric, Phillip Blanchette et al. · The Pharmacogenomics Journal · 2019 · 31 citations

Breast Oncology, Oncology, Cost-effectiveness Analysis +8